We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$355K
Cap. Flow
-$5.69M
Cap. Flow %
-3.82%
Top 10 Hldgs %
60.16%
Holding
219
New
19
Increased
55
Reduced
131
Closed
11

Top Buys

Rank Stock Value
1
SNCR
Synchronoss Technologies
SNCR
+$1.2M
2
JBL icon
Jabil
JBL
+$334K
3
LULU icon
lululemon athletica
LULU
+$248K
4
HUBB icon
Hubbell
HUBB
+$229K
5
TJX icon
TJX Companies
TJX
+$223K

Top Sells

Rank Stock Value
1
CBUS icon
Cibus
CBUS
+$1.76M
2
RPRX icon
Royalty Pharma
RPRX
+$1.56M
3
SSPY icon
Syntax Stratified LargeCap ETF
SSPY
+$972K
4
BBWI icon
Bath & Body Works
BBWI
+$456K
5
ATVI
Activision Blizzard
ATVI
+$334K

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Technology 8.1%
3 Consumer Staples 7.12%
4 Consumer Discretionary 6.29%
5 Industrials 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMCR icon
201
Amcor
AMCR
$20.8B
$117K 0.08%
+2,426
New +$111K
WT icon
202
WisdomTree
WT
$2.96B
$84.2K 0.06%
+12,152
New +$80.5K
MPT
203
Medical Properties Trust
MPT
$2.77B
$65.9K 0.04%
+13,428
New +$65.8K
DISH
204
DELISTED
DISH Network Corp.
DISH
$62.1K 0.04%
+10,771
New +$48.3K
LUMN icon
205
Lumen
LUMN
$6.57B
$60.5K 0.04%
33,038
-1,336
-4% -$1.89K
SABR icon
206
Sabre
SABR
$731M
$55.8K 0.04%
12,685
+1,594
+14% +$6.15K
SPWR
207
DELISTED
SunPower Corporation Common Stock
SPWR
$54.5K 0.04%
+11,282
New +$53.9K
CNSL
208
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$49K 0.03%
11,263
-2,587
-19% -$10.7K
AFL icon
209
Aflac
AFL
$64.9B
– –
-2,637
Closed -$202K
BBWI icon
210
Bath & Body Works
BBWI
$4.06B
– –
-13,477
Closed -$456K
BBY icon
211
Best Buy
BBY
$18.2B
– –
-3,359
Closed -$233K
GIS icon
212
General Mills
GIS
$19.1B
– –
-3,193
Closed -$204K
MCK icon
213
McKesson
MCK
$100B
– –
-471
Closed -$205K
OGN icon
214
Organon & Co
OGN
$3.56B
– –
-12,005
Closed -$208K
PAYX icon
215
Paychex
PAYX
$41.6B
– –
-1,817
Closed -$210K
RPRX icon
216
Royalty Pharma
RPRX
$25.9B
– –
-57,500
Closed -$1.56M
SEDG icon
217
SolarEdge
SEDG
$2.51B
– –
-1,655
Closed -$214K
ULTA icon
218
Ulta Beauty
ULTA
$22B
– –
-598
Closed -$239K
ATVI
219
DELISTED
Activision Blizzard
ATVI
– –
-3,563
Closed -$334K
5 6 7 8
9

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q4 2023 Portfolio in Review

As of Q4 2023, Vantage Consulting Group held 219 positions worth $149M, down 0.24% from $149M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Vantage Consulting Group withdrew a net $5.69M in Q4 2023, closing 11 positions and reducing 131 holdings. Its most notable exit was Royalty Pharma, an estimated $1.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Vantage Consulting Group opened a new position in Synchronoss Technologies worth $1.53M.

  • Vantage Consulting Group's largest Q4 2023 buy was Synchronoss Technologies: 245,947 shares worth $1.53M.
  • Vantage Consulting Group added most to TJX Companies in Q4 2023, an estimated $223K increase.
  • Vantage Consulting Group's biggest Q4 2023 reduction was Cibus, cutting an estimated $1.76M.
  • Vantage Consulting Group fully exited Royalty Pharma in Q4 2023, selling an estimated $1.56M.
  • Vantage Consulting Group's ten largest holdings make up 60% of its $149M portfolio in Q4 2023.
  • Vantage Consulting Group opened 19 new positions and closed 11 in Q4 2023.
  • Vantage Consulting Group's portfolio value fell 0.24% quarter-over-quarter to $149M.

Based on Vantage Consulting Group's 13F filing for Q4 2023, filed 14 Feb 2024.